Treatment with a peroxisome proliferator-activated receptor-α (PPARα) agonist had similar effects, attenuating the decrease in gastrocnemius weight and fast-twitch myofibre size, and preventing the arthritis-induced increase in atrogin-1 and MuRF1 expression in a rodent CIA model [126]. Here, PPARA is linked to Arthritis.